Article
Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.
PloS one - 18 Feb 2011
McFarland Adelle P, Savan Ram, Wagage Sagie, Addison Augustina, Ramakrishnan Karthika, Karwan Megan, Duong Tri, Young Howard A
Abstract excerpt
BACKGROUND: There have been conflicting reports of the role of Type I interferons (IFN) in inflammatory bowel disease (IBD). Clinical trials have shown potent efficacy of systemic interferon-beta (IFN-β) in inducing remission of ulcerative colitis. Likewise, IFNAR1(-/-) mice display an increased sensitivity to dextran sulfate sodium (DSS)-induced colitis, suggesting Type I IFN play a protective role during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
